Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
W

Wonbiogen Co Ltd
KOSDAQ:307280

Watchlist Manager
Wonbiogen Co Ltd
KOSDAQ:307280
Watchlist
Price: 2 165 KRW 1.41% Market Closed
Market Cap: ₩49.2B
Write Note Create Alert Ask AI

Wonbiogen Co Ltd
Research & Development

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also
Income Statement

Wonbiogen Co Ltd
Research & Development Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
W
Wonbiogen Co Ltd
KOSDAQ:307280
Research & Development
-₩633.7m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jeisys Medical Inc
KOSDAQ:287410
Research & Development
-₩3.4B
CAGR 3-Years
-54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Classys Inc
KOSDAQ:214150
Research & Development
-₩16.7B
CAGR 3-Years
-60%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
W
Won Tech Co Ltd
KOSDAQ:336570
Research & Development
-₩1.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
V
Viol Co Ltd
KOSDAQ:335890
Research & Development
-₩2.9B
CAGR 3-Years
-16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Seers Technology Co Ltd
KOSDAQ:458870
Research & Development
-₩4.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Wonbiogen Co Ltd
Glance View

Market Cap
49.2B KRW
Industry
Health Care

Wonbiogen Co., Ltd. engages in the research and development of biocompatible medical materials. The company is headquartered in Gumi, Gyeongsangbuk-Do. The company went IPO on 2018-12-05. The firm provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.

Intrinsic Value
2 788.67 KRW
Undervaluation 22%
Intrinsic Value
Price
W
What is Intrinsic Value?

See Also

What is Wonbiogen Co Ltd's Research & Development?
Research & Development
-633.7m KRW

Based on the financial report for Sep 30, 2025, Wonbiogen Co Ltd's Research & Development amounts to -633.7m KRW.

What is Wonbiogen Co Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
0%

Over the last year, the Research & Development growth was 39%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.